| Ligia V Onofrei, | |
|
175 N Medical Dr, Salt Lake City, UT 84132-0100 | |
| (801) 585-7575 | |
| Not Available |
| Full Name | Ligia V Onofrei |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 14 Years |
| Location | 175 N Medical Dr, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063738821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 8140996-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Utah Hospitals And Clinics | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Utah Adult Services | 0941525273 | 1459 |
News Archive
Adnavance Technologies Inc., a developer of direct detection molecular diagnostic tests for medical applications, announced today that Randy White, Ph.D. chief executive officer, will present initial data supporting direct detection of DNA targets in human clinical samples during company presentations.
Accuray Incorporated, a global leader in the field of radiosurgery, today announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family.
Knopp Neurosciences Inc. said the results of a Phase 2 safety and tolerability study of KNS-760704 in amyotrophic lateral sclerosis (ALS) will be presented at the 20th International Symposium on ALS/MND in Berlin on December 9, 2009.
Developers in medical, industrial and consumer applications continuously strive to increase wireless functionality to enhance the convenience of products. Texas Instruments today announced the first member of a new product class featuring the industry's first passive low frequency interface (PaLFI) device designed to wirelessly supply an ultra-low-power MSP430 microcontroller (MCU) with energy to operate even if the optional battery is empty.
Older adults taking the antibiotic combination trimethoprim-sulfamethoxazole (TMP-SMX)—widely prescribed for urinary tract infections—are at increased risk of elevated potassium levels, called hyperkalemia, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
› Verified 3 days ago
| Entity Name | University Of Utah Adult Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
Adnavance Technologies Inc., a developer of direct detection molecular diagnostic tests for medical applications, announced today that Randy White, Ph.D. chief executive officer, will present initial data supporting direct detection of DNA targets in human clinical samples during company presentations.
Accuray Incorporated, a global leader in the field of radiosurgery, today announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family.
Knopp Neurosciences Inc. said the results of a Phase 2 safety and tolerability study of KNS-760704 in amyotrophic lateral sclerosis (ALS) will be presented at the 20th International Symposium on ALS/MND in Berlin on December 9, 2009.
Developers in medical, industrial and consumer applications continuously strive to increase wireless functionality to enhance the convenience of products. Texas Instruments today announced the first member of a new product class featuring the industry's first passive low frequency interface (PaLFI) device designed to wirelessly supply an ultra-low-power MSP430 microcontroller (MCU) with energy to operate even if the optional battery is empty.
Older adults taking the antibiotic combination trimethoprim-sulfamethoxazole (TMP-SMX)—widely prescribed for urinary tract infections—are at increased risk of elevated potassium levels, called hyperkalemia, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ligia V Onofrei, Po Box 413027, Salt Lake City, UT 84141-3027 Ph: (801) 213-3900 | Ligia V Onofrei, 175 N Medical Dr, Salt Lake City, UT 84132-0100 Ph: (801) 585-7575 |
News Archive
Adnavance Technologies Inc., a developer of direct detection molecular diagnostic tests for medical applications, announced today that Randy White, Ph.D. chief executive officer, will present initial data supporting direct detection of DNA targets in human clinical samples during company presentations.
Accuray Incorporated, a global leader in the field of radiosurgery, today announced that the first CyberKnife VSI System to be installed in Europe was placed at the Leon-Berard Cancer Multidisciplinary Center in Lyon, France. The CyberKnife VSI System is the newest addition to the CyberKnife product family.
Knopp Neurosciences Inc. said the results of a Phase 2 safety and tolerability study of KNS-760704 in amyotrophic lateral sclerosis (ALS) will be presented at the 20th International Symposium on ALS/MND in Berlin on December 9, 2009.
Developers in medical, industrial and consumer applications continuously strive to increase wireless functionality to enhance the convenience of products. Texas Instruments today announced the first member of a new product class featuring the industry's first passive low frequency interface (PaLFI) device designed to wirelessly supply an ultra-low-power MSP430 microcontroller (MCU) with energy to operate even if the optional battery is empty.
Older adults taking the antibiotic combination trimethoprim-sulfamethoxazole (TMP-SMX)—widely prescribed for urinary tract infections—are at increased risk of elevated potassium levels, called hyperkalemia, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).
› Verified 3 days ago
Dr. Eric Thayne Monson, MD, PHD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 501 S Chipeta Way, Salt Lake City, UT 84108 Phone: 801-581-4096 | |
Dr. Gerald Martin Lazar, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 2005 E 2700 S, Suite 180, Salt Lake City, UT 84109 Phone: 801-746-2297 Fax: 801-322-3890 | |
Muharrem B. Baytunca, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-581-4096 | |
Leah M. Fortson, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: Huntsman Mental Health Institute, 501 Chipeta Way, Salt Lake City, UT 84108 Phone: 801-581-4096 | |
Norman L. Foster, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 50 N Medical Dr, Salt Lake City, UT 84132 Phone: 801-585-6387 | |
Dr. Amy Gallop, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 501 S Chipeta Way, Salt Lake City, UT 84108 Phone: 801-581-2121 | |
Lawrence H Climo, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: Comphealth 4021 South 700 East, Suite 300, Salt Lake City, UT 84107 Phone: 800-453-3030 |